The Globe and Mail reports in its Friday edition that Raymond James analyst Stephen Boland has reaffirmed his "market perform" recommendation for ECN Capital. The Globe's David Leeder writes in the Eye On Equities column that Mr. Boland gave his share target a 15-cent trim to $3.10. Analysts on average target the shares at $3.49. Mr. Boland says in a note: "We expect mixed reactions to the take-private price. Since the sale of service finance and the payment of the special dividend, the stock has struggled for a variety of reasons, including lingering COVID-related impacts on housing volumes, elevated interest rates, and operational challenges. In addition, [senior management] has undergone significant changes. We presume the purchaser group has secured commitments from the newer senior management team to support the return to growth. More details should become available when the circular is filed. Lastly, we do not expect a superior proposal. In addition to Champion's support, we believe the purchaser group has secured commitments from the company's key institutional funding partners, including Blackstone and Carlyle. It is possible those firms are part of the group to secure future loan origination opportunities."